从康美药业虚假陈述案看我国独立董事制度改进与重构 The Improvement and Reconstruction of China’s Independent Director System from the Case of Kangmei Pharmaceutical’s False Statement
席敏智 下载量: 167 浏览量: 1,070
争议解决 Vol.9 No.6, November 22 2023, PDF, HTML, XML DOI:10.12677/DS.2023.96452 被引量